New interventions rarely make large differences to patient outcomes when tested in trials. Trials that report very large effects (odds ratios ≥5 or ≤0.2) are usually small and investigate surrogate outcomes, such as laboratory test results, rather than clinical outcomes, such as death, say researchers. In …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking